N-acetyltransferase 2 activity and folate levels

Life Sciences

Volumn 86, Issue 3-4, 2010, Pages 103-106

  Cao, Wen ^a,d   Strnatka, Diana ^a   McQueen, Charlene A ^b,e   Hunter, Robert J ^a   Erickson, Robert P ^a,c  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c University of Arizona   (United States)

^d JINLING HOSPITAL   (China)

^e AUBURN UNIVERSITY   (United States)

Author keywords

"teton" system; Folic acid; N acetyltransferase; Red blood cell folate; Transgenic mice

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; COMPLEMENTARY DNA; DOXYCYCLINE; FOLIC ACID;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE LEVEL; FOLATE METABOLISM; INBRED STRAIN; KIDNEY; MOUSE; NONHUMAN; OOCYTE; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ACETYLATION; ANIMALS; ARYLAMINE N-ACETYLTRANSFERASE; CLONING, MOLECULAR; CYTOMEGALOVIRUS; DOXYCYCLINE; ERYTHROCYTES; FEMALE; FOLIC ACID; GENES, REPORTER; GENETIC VECTORS; HUMANS; ISOENZYMES; KIDNEY; LIVER; MALE; MICE; MICE, TRANSGENIC; SPECIES SPECIFICITY; TRANSGENES;

MUS; MUS MUSCULUS;

EID: 73549094922     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2009.11.008     Document Type: Article

References (31)

1. Cao W, Chau B, Hunter R, Strnatka D, McQueen CA, Erickson RP. Only low levels of exogenous N-acetyltransferase can be achieved in transgenic mice. Pharmacogenomics Journal 2005, 5:255-261.
2. Erickson RP, McQueen CA, Chau B, Gokhale V, Uchiyama M, Toyoda A, Ejima F, Maho, Sakaki Y, Gondo Y. An N-ethyl-N-nitrosourea-induced mutation in N-acetyltransferase 1 in mice. Biochemical and Biophysical Research Communications 2008, 370:285-288.
3. Erickson RP, Cao W, Acuna DK, Strnatka DW, Hunter RJ, Chau BT, Wakefield LV, Sim E, McQueen CA. Confirmation of the role of N-acetyltransferase 2 in teratogen-induced cleft palate using transgenics and knockouts. Molecular Reproduction and Development 2008, 75:1071-1076.
4. Estrada-Rodgers L, Levy GN, Weber WW. Substrate selectivity of mouse N-acetyltransferases 1, 2 and 3 expressed in COS-1 cell. Drug Metabolism and Disposition 1998, 26:502-505.
5. Fretland AJ, Doll MA, Gray K, Feng Y, Hein DW. Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterization of the activation and deactivation of aromatic amine carcinogens. Toxicology and Applied Pharmacology 1997, 142:360-366.
6. Gossen M, Freundlieb S, Bender G, Müller G, Hillen W, Bujard H. Transcriptional activation by tetracycline in mammalian cells. Science 1995, 268:1766-1769.
7. Gregory JF, Williamson J, Liao JF, Bailey LB, Toth JP. Kinetic model of folate metabolism in nonpregnant women consuming 2H2 folic acid: isotopic labeling of urinary folate and the catabolite para-acetamidobenzoylglutamate indicates slow, intake-dependent, turnover of folate pools. Journal of Nutrition 1998, 128:1896-1906.
8. Hein D.W., Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis, Mutat. Res. 506-507, 65-77, 2002.
9. Hein DW, Trinidad A, Yerokun T, Ferguson RJ, Kirlin WG, Weber WW. Genetic control of acetyl coenzyme A-dependent arylamine N-acetyltransferase, hydrazine N- acetyltransferase, and N-hydroxy-arylamine O-acetyltransferase enzymes in C57Bl/6, A/J, AC57F1 and the rapid and slow acetylator A.B6 and B6.A congenic inbred mouse. Drug Metabolism and Disposition 1988, 16:341-347.
10. Hein DW, Doll MA, Fretland AJ, Leff MA, Webb SJ, Xio GH, Devanaboyina U-S, Nangju NA, Feng Y. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiology, Biomarkers and Prevention 2000, 9:29-42.
11. Karolyi J, Erickson RP, Liu S, Killewald L. Major effects on teratogen-induced Facial clefting in mice determined by a single genetic region. Genetics 1990, 126:201-205.
12. Kawamura A, Westwood I, Wakefield L, Long H, Zhang N, Walters K, Redfield C, Sim E. Mouse N-acetyltransferase type 2, the homologue of human N-acetyltransferase type 1. Biochemical Pharmacology 2008, 75:1550-1560.
13. Kistner A, Gossen M, Zimmermann F, Jerecic J, Ullmer C, Lübbert H, Bujard H. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:933-10938.
14. Lammer EJ, Shaw GM, Iovannisci DM, Finnell RH. Periconceptional multivitamin intake during early pregnancy, genetic variation of acetyl-N-transferase 1 (NAT1), and risk for orofacial clefts. Birth Defects Research Part A: Clinical and Molecular Teratology 2004, 70:846-852.
15. Laurence KM, James N, Miller MH, Tennant GB, Campbell H. Double-blind randomized controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. British Medical Journal (Clinical Research Ed.) 1981, 282:1509-1511.
16. Liu Y, Levy GN. Activation of heterocyclic amines by combinations of prostaglandin H synthase-1 and -2 with N-acetyltransferase 1 and 2. Cancer Letters 1998, 133:115-123.
17. Martell KJ, Levy GN, Weber WW. Cloned mouse N-acetyltransferases: enzymatic properties of expressed Nat-1 and Nat-2 gene products. Molecular Pharmacology 1992, 42:265-272.
18. Mattano SS, Weber WW. Kinetics of arylamine N-acetyltransferase in tissues from rapid and slow acetylator mice. Carcinogenesis 1987, 8:133-137.
19. Mattano SS, Erickson RP, Nesbitt MN, Weber WW. Linkage of Nat and Es-1 in the mouse and development of strains congenic for N-acetyltransferase. Journal of Heredity 1988, 79:430-433.
20. McPartlin J, Courtney G, McNulty H, Weir D, Scott J. The quantitative analysis of endogenous folate catabolites in human urine. Analytical Biochemistry 1992, 206:256-261.
21. McQueen CA. Arylamine N-acetyltransferases. Current Protocols in Toxicology 2001, 4.6.1-4.6.1.13. John Wiley and Sons, New York. L.G. Costa, M.D. Maines, D.J. Reed, S. Sasa, I.G. Sipes (Eds.).
22. McQueen CA, Chau B, Erickson RP, Tjalkens RB, Philbert MA. The effects of genetic variation in N-acetyltransferases on 4-aminobiphenyl genotoxicity in mouse liver. Chemico-Biological Interactions 2003, 146:51-60.
23. Minchin RF. Acetylation of p-aminobenzoylglutamate, a folic acid catabolite, by recombinant human arylamine N-acetyltransferase and U937 cells. Biochemistry 1995, 307:1-3.
24. Payton M, Smelt V, Upton A, Sim E. A method for genotyping murine arylamine N-acetyltransferase type2 (NAT2): a gene expressed in preimplantation embryonic stem cells encoding an enzyme acetylating the folate catabolite p-aminobenzoylglutamate. Biochemical Pharmacology 1999, 58:779-785.
25. Price-Evans DA. N-Acetyltransferase. Pharmacogenetics of Drug Metabolism 1992, 95-178. Pergamon Press, New York. W. Kalow (Ed.).
26. Sim E, Pinter K, Mushtaq A, Upton A, Sandy J, Bhakta S, Noble M. Arylamine N-acetyltransferases: a pharmacogenomic approach to drug metabolism and endogenous function. Biochemical Society Transactions 2003, 31:615-619.
27. Sim E, Walters K, Boukouvala S. Arylamine N-acetyltransferases: from structure to function. Drug Metabolism Reviews 2008, 50:479-510.
28. Sugamori K, Wong S, Gaednigk A, Yu V, Abramovici H, Rozmahel R, Grant D. Generation and functional characterization of arylamine N-acetyltransferase Nat1/Nat2 double knockout mice. Molecular Pharmacology 2003, 64:170-179.
29. Wakefield L, Cornish V, Long H, Griffiths WJ, Sim E. Deletion of a xenobiotic metabolizing gene in mice affects folate metabolism. Biochemical and Biophysical Research Communications 2007, 364:556-560.
30. Wakefield L, Long H, Lack N, Sim E. Ocular defects associated with a null mutation in the mouse arylamine N-acetyltransferase 2 gene. Mammalian Genome 2007, 18:270-276.
31. Weber WW. The Acetylator Genes and Drug Response 1987, Oxford University Press, New York.